Fentanyl Citrate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

33 Suppliers, 14 USDMF, 12 CEP/COS, 3 JDMF, 4 EU WC, 4 KDMF, 16 NDC API, 17 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

DOSSIERs // Finished Dosage Forms

186 Dossiers, 77 FDA Orange Book, 68 Europe, 14 Canada, 3 South Africa, 24 Listed Dossiers

DRUG PRODUCT COMPOSITION

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE, TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 18 Roquette, 17 SPI Pharma, 17 Kerry, 11 Microlex e.U, 10 Corel Pharma Chem, 10 Sigachi Industries, 10 Gangwal Healthcare, 8 Seppic, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Actylis, 6 Lonza Capsugel, 5 Ingredion Pharma Solutions, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 DFE Pharma, 4 Prachin Chemical, 4 Vasa Pharmachem, 4 BASF, 3 Kima Chemical, 2 DKSH, 2 Pfanstiehl, 2 The Dow Chemical Company, 2 Pharmatrans-Sanaq, 2 Rochem International Inc, 1 Finar, 1 Huzhou Sunflower Pharmaceutical, 1 Alcedo Pharmachem, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Jai Radhe Sales, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Qualicaps, 1 Boai NKY Pharmaceuticals Ltd

EXCIPIENTS BY APPLICATIONS

57 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 30 Direct Compression, 28 Disintegrants & Superdisintegrants, 23 Controlled & Modified Release, 18 Taste Masking, 17 Thickeners and Stabilizers, 16 Granulation, 15 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 10 Film Formers & Plasticizers, 7 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Solubilizers, 3 Rheology Modifiers, 2 Coloring Agents, 2 Emulsifying Agents, 2 Topical

GLOBAL SALES INFORMATION

42 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

11 APIs, 5 DOSSIERS // FDF

PATENTS

36 US Patents, 17 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 1 USP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

35 News

35 News

Approved Marketing Authorisations (MA) containing Fentanyl Citrate in Europe. Original Data : EMA Website

Fentanyl Citrate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

33 Suppliers

14 USDMF

12 CEP/COS

3 JDMF

4 EU WC

4 KDMF

16 NDC API

17 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

DOSSIERs // Finished Dosage Forms

186 Dossiers

77 FDA Orange Book

68 Europe

14 Canada

3 South Africa

24 Listed Dossiers

DRUG PRODUCT COMPOSITION

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE

TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

18 Roquette

17 SPI Pharma

17 Kerry

11 Microlex e.U

10 Corel Pharma Chem

10 Sigachi Industries

10 Gangwal Healthcare

8 Seppic

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Actylis

6 Lonza Capsugel

5 Ingredion Pharma Solutions

5 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

4 DFE Pharma

4 Prachin Chemical

4 Vasa Pharmachem

4 BASF

3 Kima Chemical

2 DKSH

2 Pfanstiehl

2 The Dow Chemical Company

2 Pharmatrans-Sanaq

2 Rochem International Inc

1 Finar

1 Huzhou Sunflower Pharmaceutical

1 Alcedo Pharmachem

1 Nanjing Well Pharmaceutical

1 ACG Worldwide

1 Jai Radhe Sales

TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons